Search

  • Sort by

  • Category

  • Post Type

  • Reset

January 21, 2025: PBMs pocketed billions by inflating medicine prices, says the FTC

January 21, 2025
Posted in

A new FTC report examines how PBM business practices have inflated drug costs.

Read More

January 13, 2025: WHO warns about a fake cancer drug with English packaging

January 13, 2025
Posted in ,

WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.

Read More

October 7, 2024: DEA warning – Dozens of fake online pharmacies sold millions of fake pills to customers in all 50 states

October 7, 2024
Posted in ,

An indictment by the Department of Justice against 18 individuals who allegedly sold counterfeit pills via dozens of fake pharmacy websites to residents in all 50 states prompts warnings from two additional federal agencies.

Read More

September 30, 2024: 27 individuals indicted in Puerto Rico over wholesale distribution of misbranded and diverted medicine

September 30, 2024
Posted in ,

Twenty-seven people in Puerto Rico indicted in misbranded and diverted drug case, CBP seized counterfeit and misbranded drugs in two states, and fake arthritis and cancer medications seized in India.

Read More

PSM Compounded Weight Loss Drugs Poll

September 26, 2024
Posted in ,

PSM commissioned a survey about compounded diabetes and weight loss injectable drugs. 1,000 likely voters across political affiliations were crystal clear — they are worried about safety and the current lack of oversight. See the full results.

Read More

New studies highlight dangers of counterfeit and poorly compounded diabetes and weight-loss medicines

August 2, 2024
Posted in

A study published Friday in the Journal of the American Medical Association (JAMA) underscores the urgency.

Read More
A thumbnail of the first page of our testimony.

PSM testimony: Colorado Prescription Drug Affordability Board Meeting, June 7, 2024

May 31, 2024
Posted in , , , ,

A Colorado board is considering setting a price limit on the medicine Stelara. This will have unintended consequences, undermining the safety of the supply chain for this medicine and limiting patient access. Learn more by reading our testimony.

Read More

How Upper Payment Limits on medicine increase the risk of diverted and counterfeit medicine in the drug supply

May 28, 2024
Posted in ,

States like Colorado are experimenting with Prescription Drug Affordability Boards to address the price of medicine, but solutions like Upper Payment Limits will yield multiple unintended consequences that will do more harm than good to patients.

Read More

Alternative funding programs offshore patients and import risks

April 5, 2024
Posted in ,

Some employers are “saving money” on health insurance by hiring vendors to broker personal drug importation between their employees and unlicensed, illegal foreign pharmacies. Read more to understand the dangers of this cost-cutting practice.

Read More

Are below cost reimbursement practices by Pharmacy Benefit Managers creating opportunity for criminals to enter the legitimate supply chain?

February 5, 2024
Posted in , ,

PBMs, by under reimbursing pharmacies, are creating a demand for pharmacies to seek lower priced medications even when they can’t exist at that price.. Criminals appear to be happy to become part of the supply chain.

Read More